Article Details

mRNA Vaccine/Pembrolizumab Significantly Improves RFS in Resected Melanoma

Retrieved on: 2023-10-23 18:27:45

Tags for this article:

Click the tags to see associated articles and topics

mRNA Vaccine/Pembrolizumab Significantly Improves RFS in Resected Melanoma. View article details on HISWAI: https://www.cancernetwork.com/view/mrna-vaccine-pembrolizumab-significantly-improves-rfs-in-resected-melanoma

Excerpt

Treatment with mRNA-4157 plus pembrolizumab yields benefits in resected melanoma subgroups in the phase 2 KEYNOTE-942 trial, including those with ...

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up